Is bngo a good stock to invest in?
Mar 30, 2022 · Bionano Genomics' stock was trading at $0.5770 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BNGO shares have increased by 260.5% and is now trading at $2.08. View which stocks have been most impacted by COVID-19.
What is the price prediction for BioNano Genomics Inc (bngo) stock?
See the company profile for Bionano Genomics, Inc. (BNGO) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and ...
What is the bngo stock price prediction for 2026-06-15?
Apr 11, 2022 · View Bionano Genomics, Inc BNGO investment & stock information. Get the latest Bionano Genomics, Inc BNGO detailed stock quotes, …
How often do you update the bngo stock projections?
Apr 08, 2022 · The BioNano Genomics Inc. stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock.
What kind of stock is BNGO?
Key DataLabelValueSectorCapital GoodsIndustryBiotechnology: Laboratory Analytical Instruments1 Year Target$10.00Today's High/Low$2.18/$2.0713 more rows
Is BNGO a good buy?
Based on his analysis, DeGeeter rates BNGO stock as “outperform” with a $14 value. Other analysts are also bullish on the company. Those tracked by the Wall Street Journal have BNGO rated as a consensus “buy” with an average $12 price target.Dec 14, 2021
Is BNGO a US stock?
BNGO:USNASDAQ CM. Bionano Genomics Inc.
Is BNGO a Buy Sell or Hold?
Bionano Genomics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Who is buying BNGO stock?
Top 10 Owners of Bionano Genomics IncStockholderStakeShares bought / soldBlackRock Fund Advisors5.74%+407,569The Vanguard Group, Inc.4.86%-202,320SSgA Funds Management, Inc.2.49%-323,972Geode Capital Management LLC1.63%+42,8316 more rows
What is BNGO target price?
The 4 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 7.50, with a high estimate of 14.00 and a low estimate of 6.00. The median estimate represents a +258.85% increase from the last price of 2.09.
Is BNGO a pump and dump?
BNGO stock has suffered at the hands of a Ritalin-using pump and dump scheme making waves in 2021.May 7, 2021
Is BNGO in Russell?
(Nasdaq: BNGO) announced today that it was added as a member of the US small-cap Russell 2000® Index, effective after the US market opens on Monday, June 28, 2021, as part of the 2021 Russell indexes reconstitution.Jun 28, 2021
What does BNGO company do?
Company Description The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics.
Is Bionano Genomics FDA approved?
The Food and Drug Administration has not yet approved the device for use as a medical diagnostic tool in the U.S. However, healthcare entities can still use it for research purposes. The lack of FDA approval has also not hindered sales of the Saphyr in other countries.Jun 8, 2021
How does Bionano Genomics make money?
Revenue is produced by either directly selling the data to outsiders or by leveraging it for internal reasons, such as increasing the efficacy of advertising.
When did BNGO ipo?
August 21, 2018The units are scheduled to begin trading on The Nasdaq Capital Market under the ticker symbol “BNGOU” on August 21, 2018, and the offering is expected to close on August 23, 2018, subject to customary closing conditions.Aug 21, 2018
Is Bionano Genomics a buy right now?
3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bionano Genomics in the last year. There are currently 3...
How has Bionano Genomics' stock been impacted by Coronavirus (COVID-19)?
Bionano Genomics' stock was trading at $0.5770 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Healt...
When is Bionano Genomics' next earnings date?
Bionano Genomics is scheduled to release its next quarterly earnings announcement on Thursday, May 12th 2022. View our earnings forecast for Biona...
How were Bionano Genomics' earnings last quarter?
Bionano Genomics, Inc. (NASDAQ:BNGO) announced its quarterly earnings data on Tuesday, March, 1st. The company reported ($0.08) earnings per share...
What guidance has Bionano Genomics issued on next quarter's earnings?
Bionano Genomics updated its FY 2022 earnings guidance on Tuesday, March, 15th. The company provided earnings per share guidance of for the period....
What price target have analysts set for BNGO?
3 brokerages have issued 1-year target prices for Bionano Genomics' stock. Their forecasts range from $10.00 to $14.00. On average, they anticipate...
Who are Bionano Genomics' key executives?
Bionano Genomics' management team includes the following people: Robert Erik Holmlin , President, CEO, Secretary & Director Mark Oldakowski , Ch...
What is R. Erik Holmlin's approval rating as Bionano Genomics' CEO?
10 employees have rated Bionano Genomics CEO R. Erik Holmlin on Glassdoor.com . R. Erik Holmlin has an approval rating of 73% among Bionano Genomi...
Who are some of Bionano Genomics' key competitors?
Some companies that are related to Bionano Genomics include HORIBA (HRIBF) , Pacific Biosciences of California (PACB) , Olink Holding AB (publ)...
Is Bionano Genomics a buy right now?
What stocks does MarketBeat like better than Bionano Genomics?
4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bionano Genomics in the last year. There are currently 1 hold rating and 3 buy ratings for the stock.
When is Bionano Genomics' next earnings date?
Wall Street analysts have given Bionano Genomics a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Bionano Genomics wasn't one of them.
How were Bionano Genomics' earnings last quarter?
Bionano Genomics is scheduled to release its next quarterly earnings announcement on Friday, November 12th 2021.#N#View our earnings forecast for Bionano Genomics.
How has Bionano Genomics' stock price been impacted by COVID-19 (Coronavirus)?
Bionano Genomics, Inc. (NASDAQ:BNGO) released its quarterly earnings results on Tuesday, August, 3rd. The company reported ($0.06) EPS for the quarter, missing the Zacks' consensus estimate of ($0.04) by $0.02. The firm had revenue of $3.86 million for the quarter, compared to analysts' expectations of $3.30 million.
What price target have analysts set for BNGO?
Bionano Genomics' stock was trading at $0.5770 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BNGO shares have increased by 915.6% and is now trading at $5.86.#N#View which stocks have been most impacted by COVID-19.
What is R. Erik Holmlin's approval rating as Bionano Genomics' CEO?
4 analysts have issued 1 year price targets for Bionano Genomics' stock. Their forecasts range from $1.25 to $15.00. On average, they expect Bionano Genomics' stock price to reach $10.06 in the next twelve months.
Description
10 employees have rated Bionano Genomics CEO R. Erik Holmlin on Glassdoor.com. R. Erik Holmlin has an approval rating of 73% among Bionano Genomics' employees.
Corporate Governance
Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space.
Signals & Forecast
Bionano Genomics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Support, Risk & Stop-loss
There are mixed signals in the stock today. The BioNano Genomics Inc. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.
Is BioNano Genomics Inc. stock A Buy?
BioNano Genomics Inc. finds support from accumulated volume at $5.55 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
BNGO Target Price
BioNano Genomics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Bionano Genomics Inc ( BNGO ) Stock Market info
BNGO price target in 14 days: 6.110 USD* upside and 5.420 USD* downside. (Highest and lowest possible predicted price in a 14 day period)
Bionano Genomics Inc ( BNGO ) Stock Price Prediction, Stock Forecast for next months and years
Recommendations: Buy or sell Bionano Genomics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Bionano Genomics share forecasts, stock quote and buy / sell signals below.
